ST6GAL1 and neoplasm: In particular, tumor cells often display elevated surface sialylation as a consequence of increased expression of various Golgi sialyltransferases, including ST6 β-galactoside α2,6 sialyltransferase 1 (ST6GAL1) (10, 11).